ALL >> Marketing >> View Article
Drop In Clinical Trials In India Is A Cause Of Concern For Healthcare Research

From quite a long time, India is one of the preferred destinations for healthcare research outside the USA. Not only clinical trials but market segmentation research and testing effectiveness of new drugs were the major areas of interest for drug companies. Healthcare Market Research India brought a phenomenal boost to the economy. However, recent trends show that there is a decline in Pharma Research India. Companies prefer other countries of the third world, or they prefer China for extensive drug research. It is a cause of concern because the drop in the healthcare research means there is less investment in the sector by big multinationals.
Decline in health care research has a multidimensional impact
Market Research Agencies India suspect a big impact due to a decline in healthcare research in the country. They feel that since companies are not investing for extensive clinical trials, they will not share the formula with the Indian companies or even subsidiaries owned by them. Hence, there will be no further production of new drugs in India. Importers and consumers will be forced to pay a higher price for the ...
... same. It will make the medicines out of reach for the common people. Therefore, the government has to take measures for
regularizing the same.
How is market research being controlled in India?
Predominantly, it is being controlled by DCGI (Drug Control General India). It is a government agency that gives approval for clinical trials. It is also responsible for enforcing norms of marketing and manufacturing medicines in India. It makes sure that the research is being conducted by following the international standards. Market Research Companies Asia rate DGCI quite superior in terms of maintaining high standards of Pharma research India. With stringent controls, well-developed training modules, and high emphasis on quality, it makes sure that each product is world-class.
Advertising Research India perceives India a robust country from the regulatory perspective; it is equally true that the majority of people in the country are illiterate and poor. They can’t afford big spending on medicines and rely on low-quality local drugs. Hence, they are vulnerable to side-effects and unethical trials. It is important that pharmaceutical companies take measures to make people aware of the importance of good quality medicines. Since branded drugs pass through the process of clinical trials, there is the minimal possibility of mishaps. Structured and coordinated efforts by pharmaceutical companies, research institutes, and regulatory authorities will boost the clinical trials in India.
Add Comment
Marketing Articles
1. Online Car Auctions – Bid On Quality Used Cars TodayAuthor: pushpa chauhan
2. Best Data Analytics Courses Online: Elevate Your Career With Career Lab Consulting
Author: Career Lab Consulting
3. Is It Possible To Watch Instagram Stories Secretly? Exploring Anonymous Viewers
Author: richard
4. What To Expect From An Affordable Seo Service In The Uk
Author: Cartoozo
5. Steel Structures & Metal Buildings (ssmb) Magazine - Advancing Steel Construction In India
Author: Steel Structures & Metal Buildings (SSMB) Magazine
6. Digital Marketing Services At Cheap Rates | Brand Roof Solutions
Author: Brand Roof Solutions
7. 500w Solar Panels: Powering Your Home And Business In Australia
Author: Kunal
8. Content Marketing: The Reign Of Authenticity
Author: Impaakt Magazine
9. Top 5 Marketing Companies In Bhopal You Should Know
Author: justin
10. Marketing Automation In B2b Marketing: Simplifying Success
Author: tim seifert
11. How To Find A Reliable Website Marketing Company
Author: Peggy Police
12. Professional Email Marketing Services In India That Deliver Results
Author: Roi Hunt
13. The Role Of Marketing Companies In Brand Development
Author: Barry Elvis
14. Why Onstipe Is The Best Social Media Aggregator Tool In 2025
Author: richard
15. Why Cheap Logo Designs Can Harm Your Brand Reputation
Author: Brandrisic Media